Search Login Register

Gangliosides Summary

Description: A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997)

Also Known As: Sialoglycosphingolipids

Networked: 1633 relevant articles (35 outcomes, 154 trials/studies) for this Bio-Agent

Key Diseases for which Gangliosides is Relevant

  1. Neoplasms (Cancer) : 5 outcomes 25 studies in 402 results
  2. Diabetic Neuropathies (Diabetic Neuropathy) : 4 outcomes 5 studies in 17 results
  3. Stroke (Strokes) : 3 outcomes 2 studies in 9 results
  4. Melanoma (Melanoma, Malignant) : 2 outcomes 15 studies in 157 results
  5. Neuroblastoma : 2 outcomes 14 studies in 117 results
Show All >>

Drugs Related to Gangliosides

  1. Antibodies
  2. Immunoglobulin M (IgM)
  3. cronassial
  4. Immunoglobulin G (IgG)
  5. Phospholipids
  6. Cholesterol
  7. Epitopes
  8. Neuraminidase (Sialidase)
  9. Immunoglobulins (Immunoglobulin)
  10. gangliotetraose
Show All >>

Therapies Related to Gangliosides

  1. Intramuscular Injections
  2. Immunomodulation
  3. Immunotherapy
  4. Heterologous Transplantation (Xenotransplantation)
  5. Transplantation (Transplant Recipients)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.